ImmunoCellular Therapeutics, Ltd. (AMEX:IMUC) is considering strategic alternatives. ImmunoCellular Therapeutics has been actively engaged in a broad range of conversations with potential strategic partners to explore strategic alternatives, which may include a potential merger, consolidation, reorganization or other business combination, as well as the sale of the ImmunoCellular Therapeutics or its assets. These conversations have included the exchange of detailed information to determine the potential for an alignment of programs and strategies, as well as possible options for continuing to fund operation. ImmunoCellular Therapeutics plans to continue this exploratory process with the assistance of its external strategic financial advisor, but cannot guarantee that any actions will be taken as a direct result of this review.